Oxford Wealth Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.84M Sell
2,371
-7
-0.3% -$7.15K 1.27% 29
2026
Q1
$2.19M Buy
2,378
+5
+0.2% +$5.07K 1.19% 30
2025
Q4
$2.55M Buy
+2,373
New +$2.27M 1.24% 28
2024
Q4
$2.81M Buy
3,636
+220
+6% +$182K 1.81% 12
2024
Q3
$3.03M Sell
3,416
-621
-15% -$558K 2.46% 11
2024
Q2
$3.66M Buy
4,037
+339
+9% +$271K 2.51% 11
2024
Q1
$2.88M Buy
+3,698
New +$2.63M 2.62% 9

Other funds holding LLY

Oxford Wealth Group's LLY Position: Q2 2026 in Review

Oxford Wealth Group reduced its Eli Lilly (LLY) stake by 0.29% in Q2 2026, selling an estimated $7.15K and leaving 2,371 shares worth $2.84M. The position accounts for 1.27% of the portfolio, ranked #29.

Oxford Wealth Group first reported a position in LLY in Q1 2024 and has held it in 7 quarters since. The position peaked at $3.66M in Q2 2024. 4,640 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Oxford Wealth Group held 2,371 shares of Eli Lilly worth $2.84M as of Q2 2026.
  • Oxford Wealth Group sold 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
  • Eli Lilly made up 1.27% of Oxford Wealth Group's portfolio in Q2 2026, its #29 holding.
  • Oxford Wealth Group first reported a position in Eli Lilly in Q1 2024 and has held it in 7 quarters since.
  • Oxford Wealth Group's Eli Lilly position peaked at $3.66M in Q2 2024.
  • 4,640 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Oxford Wealth Group's 13F filing for Q2 2026, filed 13 Aug 2026.